Funding
Turn ideas into impact
Show Me
Due: January 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-070
Due: January 7, 2027
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 – Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-377
Due: January 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-026
Due: January 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
US $1,515,000
Type
Grant
Source
Federal
Opp Number
PAR-25-025
Due: January 8, 2027
NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk
US $2,000,000
Type
Grant
Source
Federal
Due: January 15, 2027
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 – Clinical Trial Not Allowed)
US $350,000
Type
Grant
Source
Federal
Opp Number
RFA-NS-25-023
Due: January 24, 2027
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement
US $1,000,000
Type
Grant
Source
Federal
Due: January 25, 2027
Medical Scientist Training Program (MSTP) (T32)
Type
Grant
Source
Federal
Opp Number
PAR-24-128
Due: January 27, 2027
Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-24-260
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?